Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mohammad Reza Hatamnejad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, University of California Lo…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Heart Failure, Myocardial Ischemia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, American Heart Association.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The effect of the gut microbiota extends beyond their habitant place from the gastrointestinal tract to distant organs, including the cardiovascular system. Research interest in the relationship between the heart and the gut microbiota has recently been emerging. The gut microbiota secretes metabolites, including Trimethylamine N-oxide (TMAO), short-chain fatty acids (SCFAs), bile acids (BAs), indole propionic acid (IPA), hydrogen sulfide (H2S), and phenylacetylglutamine (PAGln). In this review, we explore the accumulating evidence on the role of these secreted microbiota metabolites in the pathophysiology of ischemic and non-ischemic heart failure (HF) by summarizing current knowledge from clinical studies and experimental models. Elevated TMAO contributes to non-ischemic HF through TGF-ß/Smad signaling-mediated myocardial hypertrophy and fibrosis, impairments of mitochondrial energy production, DNA methylation pattern change, and intracellular calcium transport. Also, high-level TMAO can promote ischemic HF via inflammation, histone methylation-mediated vascular fibrosis, platelet hyperactivity, and thrombosis, as well as cholesterol accumulation and the activation of MAPK signaling. Reduced SCFAs upregulate Egr-1 protein, T-cell myocardial infiltration, and HDAC 5 and 6 activities, leading to non-ischemic HF, while reactive oxygen species production and the hyperactivation of caveolin-ACE axis result in ischemic HF. An altered BAs level worsens contractility, opens mitochondrial permeability transition pores inducing apoptosis, and enhances cholesterol accumulation, eventually exacerbating ischemic and non-ischemic HF. IPA, through the inhibition of nicotinamide N-methyl transferase expression and increased nicotinamide, NAD+/NADH, and SIRT3 levels, can ameliorate non-ischemic HF; meanwhile, H2S by suppressing Nox4 expression and mitochondrial ROS production by stimulating the PI3K/AKT pathway can also protect against non-ischemic HF. Furthermore, PAGln can affect sarcomere shortening ability and myocyte contraction. This emerging field of research opens new avenues for HF therapies by restoring gut microbiota through dietary interventions, prebiotics, probiotics, or fecal microbiota transplantation and as such normalizing circulating levels of TMAO, SCFA, BAs, IPA, H2S, and PAGln.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, BH-550 CHS, Los Angeles, CA 90095-7115, USA.
ORCID-Profile: Mohammad Reza Hatamnejad, Mansoureh Eghbali
Förderung
- NHLBI NIH HHS
- NIH HHS
- American Heart Association
- National Institutes of Health
Zitieren
APA
Hatamnejad, M. R., Medzikovic, L., Dehghanitafti, A., Rahman, B., Vadgama, A., & Eghbali, M. (2025). Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052242
Vancouver
Hatamnejad MR, Medzikovic L, Dehghanitafti A, Rahman B, Vadgama A, Eghbali M. Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052242
BibTeX
@article{Hatamnejad2025,
author = {Hatamnejad, Mohammad Reza and Medzikovic, Lejla and Dehghanitafti, Ateyeh and Rahman, Bita and Vadgama, Arjun and Eghbali, Mansoureh},
title = {Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052242}
}
EUVIMED